References
- O’Donovan MC, Craddock N, Norton N, et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet. 2008;40(9):1053–1055.
- Walters JT, Corvin A, Owen MJ, et al. Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch Gen Psychiatry. 2010; 67(7):692–700.
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Publishing; 2013.
- Kaplan HI, Sadock BJ. Kaplan and Sadock’s synopsis of psychiatry: behavioral sciences clinical psychiatry. 7th ed. Williams & Wilkins: Baltimore, MD, 1994.
- McGrath J, Saha S, Chant D, et al. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008; 30(1):67–76.
- Parmanand K, Ruchita S, Aarya KR. An overview of Indian research in schizophrenia. Indian J Psychiatry. 2010; 52(Suppl1):S159–S172.
- Birnbaum R, Weinberger DR. Genetic insights into the neurodevelopmental origins of schizophrenia. Nat Rev Neurosci. 2017; 18(12):727–740.
- Kendler KS, Diehl SR. The genetics of Schizophrenia: a current, genetic- epidemiologic Perspective. Schizophrenia Bull. 1993;19(2):261–285.
- Li M, Luo XJ, Xiao X, et al. Allelic differences between Han Chinese and Europeans for functional variants in ZNF804A and their association with schizophrenia. Am J Psychiatry. 2011; 168(12):1318–1325.
- Bergen SE, Petryshen TL. Genome-wide association studies of schizophrenia: does bigger lead to better results?Curr Opin Psychiatry. 2012;25(2):76–82.
- Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421–427.
- Chang H, Xiao X, Li M. The schizophrenia risk gene ZNF804A: clinical associations, biological mechanisms and neuronal functions. Mol Psychiatry. 2017; 22(7):944–953.
- Tao R, Cousijn H, Jaffe AE, et al. Expression of ZNF804A in human brain and alterations in schizophrenia, bipolar disorder, and major depressive disorder: a novel transcript fetally regulated by the psychosis risk variant rs1344706. JAMA Psychiatry. 2014; 71(10):1112–1120.
- Zhou Y, Dong F, Lanz TA, et al. Interactome analysis reveals ZNF804A, a schizophrenia risk gene, as a novel component of protein translational machinery critical for embryonic neurodevelopment. Mol Psychiatry. 2018; 23(4):952–962.
- Snitz BE, Macdonald AW, 3rd, Carter CS. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr Bull. 2005;32(1):179–194.
- Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci. 2006; 7(10):818–827.
- Mössner R, Schuhmacher A, Wagner M, et al. The schizophrenia risk gene ZNF804A influences the antipsychotic response of positive schizophrenia symptoms. Eur Arch Psychiatry Clin Neurosci. 2012; 262(3):193–197.
- Esslinger C, Walter H, Kirsch P, et al. Neural mechanisms of a genome-wide supported psychosis variant. Science. 2009; 324(5927):605.
- Walter H, Schnell K, Erk S, et al. Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task. Mol Psychiatry. 2011; 16(4):462–470.
- Riley B, Thiselton D, Maher BS, et al. Replication of association between schizophrenia and ZNF804A in the Irish Case-Control Study of Schizophrenia sample. Mol Psychiatry. 2010; 15(1):29–37.
- Li M, Zhang H, Luo XJ, et al. Meta-analysis indicates that the European GWAS-identified risk SNP rs1344706 within ZNF804A is not associated with schizophrenia in Han Chinese population. PLoS One. 2013;8(6):e65780.
- Steinberg S, Mors O, Borglum AD, GROUP, et al. Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry. 2011;16(1):59–66.
- Zhang R, Lu SM, Qiu C, et al. Population-based and family-based association studies of ZNF804A locus and schizophrenia. Mol Psychiatry. 2011; 16(4):360–361.
- Williams HJ, Norton N, Dwyer S, et al. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry. 2011;16(4):429–441.